Opportunities for Conventional and In Situ Cancer Vaccine Strategies and Combination with Immunotherapy for Gastrointestinal Cancers, A Review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Opportunities for Conventional and In Situ Cancer Vaccine Strategies and Combination with Immunotherapy for Gastrointestinal Cancers, A Review
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 5, Pages 1121
Publisher
MDPI AG
Online
2020-05-05
DOI
10.3390/cancers12051121
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
- (2020) Isaure Vanmeerbeek et al. OncoImmunology
- Strong vaccine responses during chemotherapy are associated with prolonged cancer survival
- (2020) Cornelis J. M. Melief et al. Science Translational Medicine
- Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses
- (2019) Karim Vermaelen Frontiers in Immunology
- Turning the corner on therapeutic cancer vaccines
- (2019) Robert E. Hollingsworth et al. npj Vaccines
- Phase 1 Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines emulsified in Montanide ISA 720VG and nor-MDP Adjuvant in Advanced Solid Tumors
- (2019) Tanios Bekaii-Saab et al. CLINICAL CANCER RESEARCH
- Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors
- (2019) Fangjun Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
- (2019) Leonie Voorwerk et al. NATURE MEDICINE
- A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy
- (2019) Masahiro Katsuda et al. Trials
- The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
- (2019) Kalijn F. Bol et al. Journal for ImmunoTherapy of Cancer
- Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1
- (2019) Zensho Ito et al. ONCOLOGY
- Ionizing radiation effects on the tumor microenvironment
- (2019) Luigi Portella et al. SEMINARS IN ONCOLOGY
- Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade
- (2019) Oliver Kepp et al. OncoImmunology
- Trial watch: dendritic cell vaccination for cancer immunotherapy
- (2019) Jenny Sprooten et al. OncoImmunology
- Combined Checkpoint Inhibition and Chemotherapy: New Era of 1st-Line Treatment for Non-Small-Cell Lung Cancer
- (2019) Chongkai Wang et al. Molecular Therapy-Oncolytics
- Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds
- (2019) Venkatesh Sivanandam et al. Molecular Therapy-Oncolytics
- A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial
- (2019) Robert A. Belderbos et al. Translational Lung Cancer Research
- Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer
- (2019) Danyang Sun et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer
- (2019) Alessandro Leonetti et al. DRUG RESISTANCE UPDATES
- The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review
- (2019) Luca Mazzarella et al. EUROPEAN JOURNAL OF CANCER
- Combination therapy with PD-1 or PD-L1 inhibitors for cancer
- (2019) Hidetoshi Hayashi et al. International Journal of Clinical Oncology
- The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer
- (2019) Vanessa Barriga et al. Cancers
- Radiation as an In Situ Auto-Vaccination: Current Perspectives and Challenges
- (2019) Goto Vaccines
- Repurposing the yellow fever vaccine for intratumoral immunotherapy
- (2019) Maria Angela Aznar et al. EMBO Molecular Medicine
- A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)‐Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer
- (2019) Margaret E. Gatti‐Mays et al. ONCOLOGIST
- Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade
- (2019) Tala Shekarian et al. Science Translational Medicine
- High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy
- (2019) Angela Mauriello et al. Cancers
- Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
- (2019) Jenna H. Newman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD4+ T cell help creates memory CD8+ T cells with innate and help-independent recall capacities
- (2019) Tomasz Ahrends et al. Nature Communications
- A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer
- (2019) Mark Yarchoan et al. Cancer Medicine
- Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights
- (2019) Sonal Patel et al. Frontiers in Immunology
- Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines
- (2018) Stephen J. Russell et al. CANCER CELL
- Toxicities Associated With PD-1/PD-L1 Blockade
- (2018) Daniel Y. Wang et al. CANCER JOURNAL
- Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
- (2018) Jason Chesney et al. JOURNAL OF CLINICAL ONCOLOGY
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Reimagining the diagnostic pathway for gastrointestinal cancer
- (2018) Greg Rubin et al. Nature Reviews Gastroenterology & Hepatology
- Dendritic cells as cancer therapeutics
- (2018) Christian E. Bryant et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Correlates of immune and clinical activity of novel cancer vaccines
- (2018) Sjoerd H. van der Burg SEMINARS IN IMMUNOLOGY
- In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree
- (2018) Mee Rie Sheen et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma
- (2018) Thitinee Vanichapol et al. Biomed Research International
- Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites
- (2018) Zachary S. Morris et al. Cancer Immunology Research
- Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses
- (2018) Teresa Nguyen et al. Cancers
- Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies
- (2018) Qiang Wang et al. CANCER LETTERS
- Chemotherapy Combines Effectively with Anti–PD-L1 Treatment and Can Augment Antitumor Responses
- (2018) Rafael Cubas et al. JOURNAL OF IMMUNOLOGY
- In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
- (2018) Matthew J. Frank et al. Cancer Discovery
- Radiation and Local Anti-CD40 Generate an Effective in situ Vaccine in Preclinical Models of Pancreatic Cancer
- (2018) Sayeda Yasmin-Karim et al. Frontiers in Immunology
- Trial watch: peptide-based vaccines in anticancer therapy
- (2018) Lucillia Bezu et al. OncoImmunology
- Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related Cancer
- (2018) Erminia Massarelli et al. JAMA Oncology
- Autologous dendritic cell-cytokine induced killer cell immunotherapy combined with S-1 plus cisplatin in patients with advanced gastric cancer: A prospective study
- (2018) Guoliang Qiao et al. CLINICAL CANCER RESEARCH
- Radiotherapy and immune response: the systemic effects of a local treatment
- (2018) HA Carvalho et al. Clinics
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Cancer immunotherapy sweeps Nobel for medicine
- (2018) Jocelyn Kaiser et al. SCIENCE
- Effectiveness and safety of PD-1/PD-L1 or CTLA4 inhibitors combined with chemotherapy as a first-line treatment for lung cancer: A meta-analysis
- (2018) Kaikai Shen et al. Journal of Thoracic Disease
- TCR Repertoire as a Novel Indicator for Immune Monitoring and Prognosis Assessment of Patients With Cervical Cancer
- (2018) Jin-Huan Cui et al. Frontiers in Immunology
- Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
- (2018) Nataschja I. Ho et al. Frontiers in Immunology
- Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time
- (2018) Wouter W. van Willigen et al. Frontiers in Immunology
- Beyond the PD-L1 horizon: In search for a good biomarker to predict success of immunotherapy in gastric and esophageal adenocarcinoma
- (2018) Willem J. Koemans et al. CANCER LETTERS
- CD4 + T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness
- (2017) Tomasz Ahrends et al. IMMUNITY
- Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
- (2017) Glen J. Weiss et al. INVESTIGATIONAL NEW DRUGS
- HBV-Derived Synthetic Long Peptide Can Boost CD4+ and CD8+ T-Cell Responses in Chronic HBV Patients Ex Vivo
- (2017) Yingying Dou et al. JOURNAL OF INFECTIOUS DISEASES
- Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
- (2017) Jacob Schachter et al. LANCET
- Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
- (2017) Narek Shaverdian et al. LANCET ONCOLOGY
- The mechanisms tumor cells utilize to evade the host's immune system
- (2017) Nyanbol Kuol et al. MATURITAS
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
- (2017) Vinod P. Balachandran et al. NATURE
- A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
- (2017) Marta Łuksza et al. NATURE
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Tumour virus vaccines: hepatitis B virus and human papillomavirus
- (2017) Margaret Stanley PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
- (2017) Claire Vanpouille-Box et al. Nature Communications
- Regulatory T cells in cancer immunotherapy
- (2016) Atsushi Tanaka et al. CELL RESEARCH
- Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells
- (2016) Chad Tang et al. CLINICAL CANCER RESEARCH
- Dendritic Cell-Based Immunotherapy: State of the Art and Beyond
- (2016) K. F. Bol et al. CLINICAL CANCER RESEARCH
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- In situvaccination for the treatment of cancer
- (2016) Linda Hammerich et al. Immunotherapy
- A Prospective Clinical Trial Combining Radiation Therapy With Systemic Immunotherapy in Metastatic Melanoma
- (2016) Susan M. Hiniker et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
- (2016) Igor Puzanov et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloid-derived suppressor cells in gastrointestinal cancers: A systematic review
- (2016) Armin Hirbod-Mobarakeh et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
- (2016) Hong Jiang et al. NATURE MEDICINE
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses
- (2016) Marij J. Welters et al. Science Translational Medicine
- Combining targeted therapy with immunotherapy. Can 1+1 equal more than 2?
- (2016) Lidia Robert et al. SEMINARS IN IMMUNOLOGY
- Peptide-based synthetic vaccines
- (2016) Mariusz Skwarczynski et al. Chemical Science
- Molecular mechanisms for enhanced DNA vaccine immunogenicity
- (2015) Lei Li et al. Expert Review of Vaccines
- Spatiotemporally Distinct Interactions with Dendritic Cell Subsets Facilitates CD4+ and CD8+ T Cell Activation to Localized Viral Infection
- (2015) Jyh Liang Hor et al. IMMUNITY
- Therapeutic cancer vaccines
- (2015) Cornelis J.M. Melief et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
- (2015) Cornelia L Trimble et al. LANCET
- In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf
- (2015) Linda Hammerich et al. Molecular Oncology
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiotherapy and Immunogenic Cell Death
- (2015) Encouse B. Golden et al. SEMINARS IN RADIATION ONCOLOGY
- Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
- (2015) A. J. Gunderson et al. Cancer Discovery
- In-situ tumor vaccination: Bringing the fight to the tumor
- (2015) Robert H Pierce et al. Human Vaccines & Immunotherapeutics
- In situ vaccine, immunological memory and cancer cure
- (2015) Kangla Tsung et al. Human Vaccines & Immunotherapeutics
- Investigating Evolutionary Conservation of Dendritic Cell Subset Identity and Functions
- (2015) Thien-Phong Vu Manh et al. Frontiers in Immunology
- Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma
- (2015) Michael A. Postow et al. Journal for ImmunoTherapy of Cancer
- Stromal reengineering to treat pancreas cancer
- (2014) I. M. Stromnes et al. CARCINOGENESIS
- Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients
- (2014) S. Occhipinti et al. CLINICAL CANCER RESEARCH
- Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
- (2014) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- Two in one: improving synthetic long peptide vaccines by combining antigen and adjuvant in one molecule
- (2014) Gijs G Zom et al. OncoImmunology
- A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer
- (2014) Paul LR Mitchell et al. Journal for ImmunoTherapy of Cancer
- Transcriptionally Active Human Papillomavirus Is Strongly Associated With Barrett's Dysplasia and Esophageal Adenocarcinoma
- (2013) Shanmugarajah Rajendra et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
- (2013) L Bracci et al. CELL DEATH AND DIFFERENTIATION
- Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation
- (2013) Rodney A. Rosalia et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
- (2013) Mariette I E van Poelgeest et al. Journal of Translational Medicine
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- The Combination of a Low-Dose Chemotherapeutic Agent, 5-Fluorouracil, and an Adenoviral Tumor Vaccine Has a Synergistic Benefit on Survival in a Tumor Model System
- (2013) Sean M. Geary et al. PLoS One
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer
- (2013) E. B. Golden et al. Cancer Immunology Research
- Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells
- (2012) Venkataswarup Tiriveedhi et al. BREAST CANCER RESEARCH AND TREATMENT
- DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time
- (2012) Lindsey Chudley et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Induction of Abscopal Anti-Tumor Immunity and Immunogenic Tumor Cell Death by Ionizing Irradiation - Implications for Cancer Therapies
- (2012) B. Frey et al. CURRENT MEDICINAL CHEMISTRY
- Radiation Therapy to Convert the Tumor Into an In Situ Vaccine
- (2012) Silvia C. Formenti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
- (2012) Alfons JM van den Eertwegh et al. LANCET ONCOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses
- (2012) M. L. Bagarazzi et al. Science Translational Medicine
- Prerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy
- (2011) Dalil Hannani et al. CANCER JOURNAL
- Immunologic Response to Xenogeneic gp100 DNA in Melanoma Patients: Comparison of Particle-Mediated Epidermal Delivery with Intramuscular Injection
- (2010) B. A. Ginsberg et al. CLINICAL CANCER RESEARCH
- The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8α+dendritic cells
- (2010) Karine Crozat et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human CD141+(BDCA-3)+dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
- (2010) Sarah L. Jongbloed et al. JOURNAL OF EXPERIMENTAL MEDICINE
- DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) Elicits Long-term T-cell Responses in Patients With Recurrent Prostate Cancer
- (2010) Jordan T. Becker et al. JOURNAL OF IMMUNOTHERAPY
- Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial
- (2010) Håkan Norell et al. Journal of Translational Medicine
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-
- (2010) M. Kraman et al. SCIENCE
- A Phase I safety study of plasmid DNA immunization targeting carcinoembryonic antigen in colorectal cancer patients
- (2010) Caroline Staff et al. VACCINE
- Introduction to Cancer Chemotherapeutics
- (2009) Donna S. Shewach et al. CHEMICAL REVIEWS
- Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer
- (2009) Douglas G. McNeel et al. JOURNAL OF CLINICAL ONCOLOGY
- In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
- (2009) Franck Pagès et al. JOURNAL OF CLINICAL ONCOLOGY
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity
- (2008) Cédric Ménard et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunogenic anti-cancer chemotherapy as an emerging concept
- (2008) Nicole M Haynes et al. CURRENT OPINION IN IMMUNOLOGY
- Initial lessons learned in HPV vaccination
- (2008) Thomas J. Herzog et al. GYNECOLOGIC ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now